Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$154K Sell
1,824
-868
-32% -$70K ﹤0.01% 879
2026
Q1
$190K Sell
2,692
-206
-7% -$15.4K ﹤0.01% 788
2025
Q4
$229K Sell
2,898
-687
-19% -$54.4K ﹤0.01% 729
2025
Q3
$295K Buy
3,585
+125
+4% +$9.84K ﹤0.01% 674
2025
Q2
$278K Buy
3,460
+867
+33% +$66.9K ﹤0.01% 656
2025
Q1
$208K Sell
2,593
-1,847
-42% -$154K ﹤0.01% 692
2024
Q4
$364K Sell
4,440
-3,382
-43% -$281K ﹤0.01% 468
2024
Q3
$549K Buy
7,822
+2,664
+52% +$199K 0.01% 428
2024
Q2
$382K Buy
5,158
+1,001
+24% +$71.5K 0.01% 480
2024
Q1
$308K Buy
4,157
+680
+20% +$47.4K ﹤0.01% 387
2023
Q4
$218K Buy
3,477
+256
+8% +$16K ﹤0.01% 425
2023
Q3
$182K Buy
3,221
+1,086
+51% +$67.6K ﹤0.01% 457
2023
Q2
$124K Sell
2,135
-3,809
-64% -$211K ﹤0.01% 459
2023
Q1
$430K Buy
5,944
+103
+2% +$6.95K 0.01% 326
2022
Q4
$355K Buy
5,841
+2,137
+58% +$153K 0.01% 321
2022
Q3
$233K Buy
3,704
+946
+34% +$60.4K ﹤0.01% 322
2022
Q2
$194K Buy
+2,758
New +$183K ﹤0.01% 327

Other funds holding MET

Blue Trust Inc's MET Position: Q2 2026 in Review

Blue Trust Inc reduced its MetLife (MET) stake by 32% in Q2 2026, selling an estimated $70K and leaving 1,824 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #879.

Blue Trust Inc first reported a position in MET in Q2 2022 and has held it in 17 quarters since. The position peaked at $549K in Q3 2024. 423 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Blue Trust Inc held 1,824 shares of MetLife worth $154K as of Q2 2026.
  • Blue Trust Inc sold 868 MetLife shares in Q2 2026, an estimated $70K.
  • MetLife made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #879 holding.
  • Blue Trust Inc first reported a position in MetLife in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's MetLife position peaked at $549K in Q3 2024.
  • 423 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.